{"transactions":[{"id":743256,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:04.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265905","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526265905/ownership.xml","form_type":"4"}},{"id":963708,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-18T23:39:56.000Z","date":"2025-12-16","kind":"grant","planned":false,"acquired":true,"shares":7819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such date."}],"balance_after":46215,"source":{"system":"sec-edgar","filing":"0001190644-25-000004","document":"wk-form4_1766101193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000119064425000004/wk-form4_1766101193.xml","form_type":"4"}},{"id":976898,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":269542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs are subject to service- and performance-based vesting criteria."}],"balance_after":929391,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976897,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":96541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person was granted Performance Shares, as described in the Company's 2018 Equity Incentive Plan. The Performance Shares are subject to service- and performance-based vesting criteria."}],"balance_after":659849,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976896,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":73001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person was granted Performance Units, as described in the Company's 2018 Equity Incentive Plan. The Performance Units are subject to service- and performance-based vesting criteria."}],"balance_after":563308,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976895,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted shares, as described in the Company's 2018 Equity Incentive Plan. The restricted shares are subject to service- and performance-based vesting criteria."}],"balance_after":490307,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976894,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted performance-contingent restricted stock units (\"Performance-Contingent RSUs\"), as described in the Company's 2018 Equity Incentive Plan. Each Performance-Contingent RSU represents the right to receive one share of common stock. The Performance-Contingent RSUs are subject to service- and performance-based vesting criteria."}],"balance_after":440307,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":1119829,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:51:59.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025083311/ownership.xml","form_type":"4"}},{"id":1279385,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-07T22:57:52.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":38396,"price":20.09,"value":771375.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units with a grant date 02/06/2025, which will vest in three years."}],"balance_after":38396,"source":{"system":"sec-edgar","filing":"0001628280-25-004478","document":"wk-form4_1738969065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828025004478/wk-form4_1738969065.xml","form_type":"4"}},{"id":1490172,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T00:03:59.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":102225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2024 with respect to 102,225 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":102225,"derivative":{"exercise_price":6.79,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":102225},"source":{"system":"sec-edgar","filing":"0000950170-24-069556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024069556/ownership.xml","form_type":"4"}},{"id":1749114,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-06T13:00:10.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":81.26,"value":16252.0,"ownership":{"direct":true},"balance_after":390307,"source":{"system":"sec-edgar","filing":"0001209191-23-054441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054441/doc4.xml","form_type":"4"}},{"id":1749113,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-06T13:00:10.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":3884,"price":80.33,"value":312001.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.08 to $80.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":390107,"source":{"system":"sec-edgar","filing":"0001209191-23-054441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054441/doc4.xml","form_type":"4"}},{"id":1749112,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-06T13:00:10.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":11060,"price":79.7,"value":881482.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.05 to $80.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":386223,"source":{"system":"sec-edgar","filing":"0001209191-23-054441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054441/doc4.xml","form_type":"4"}},{"id":1749111,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-06T13:00:10.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":10081,"price":78.57,"value":792064.17,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.03 to $79.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":375163,"source":{"system":"sec-edgar","filing":"0001209191-23-054441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054441/doc4.xml","form_type":"4"}},{"id":1872170,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T22:42:20.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":66055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 31, 2023 with respect to 66,055 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":66055,"derivative":{"exercise_price":11.14,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":66055},"source":{"system":"sec-edgar","filing":"0001209191-23-033442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123033442/doc4.xml","form_type":"4"}},{"id":2253661,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T21:39:34.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":41597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":41597,"derivative":{"exercise_price":17.33,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":41597},"source":{"system":"sec-edgar","filing":"0001209191-22-032682","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122032682/doc4.xml","form_type":"4"}},{"id":2508939,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-17T23:24:20.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":25026,"price":79.94,"value":2000578.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.62 to $80.06, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":365082,"source":{"system":"sec-edgar","filing":"0001209191-21-065246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121065246/doc4.xml","form_type":"4"}},{"id":2654139,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-29T00:00:52.000Z","date":"2021-06-26","kind":"tax_withholding","acquired":false,"shares":17812,"price":80.4,"value":1432084.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."}],"balance_after":340056,"source":{"system":"sec-edgar","filing":"0001209191-21-043582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121043582/doc4.xml","form_type":"4"}},{"id":2701071,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T23:42:00.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 19, 2021 with respect to 16,000 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":16000,"derivative":{"exercise_price":30.09,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-21-035112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121035112/doc4.xml","form_type":"4"}},{"id":2926643,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-05T01:00:36.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":37144,"price":170.49,"value":6332680.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."}],"balance_after":357868,"source":{"system":"sec-edgar","filing":"0001209191-21-000556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121000556/doc4.xml","form_type":"4"}},{"id":3078931,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T23:15:28.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":25000,"price":20,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 20, 2020, the reporting person purchased 25,000 shares of common stock, par value $0.001 per share, of the Issuer at a price of $20.00 per share pursuant to an underwritten public offering."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000899243-20-019841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000089924320019841/doc4.xml","form_type":"4"}},{"id":3324963,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-01-04T01:00:53.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":37185,"price":129.04,"value":4798352.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."}],"balance_after":395012,"source":{"system":"sec-edgar","filing":"0001209191-20-001424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120001424/doc4.xml","form_type":"4"}},{"id":3441687,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:48:13.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":7792,"price":123.41,"value":961610.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in multiple transactions at prices ranging from $123.22 to $123.79, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":432197,"source":{"system":"sec-edgar","filing":"0001209191-19-045578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119045578/doc4.xml","form_type":"4"}},{"id":3441686,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:48:13.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":8460,"price":122.76,"value":1038549.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $122.16 to $123.00, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":424405,"source":{"system":"sec-edgar","filing":"0001209191-19-045578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119045578/doc4.xml","form_type":"4"}},{"id":3780882,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-10-30T23:05:39.000Z","date":"2018-10-30","kind":"purchase","acquired":true,"shares":3134,"price":120.94,"value":379025.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in multiple transactions at prices ranging from $120.81 to $121.00, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":415945,"source":{"system":"sec-edgar","filing":"0001209191-18-056571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056571/doc4.xml","form_type":"4"}},{"id":3780881,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-10-30T23:05:39.000Z","date":"2018-10-30","kind":"purchase","acquired":true,"shares":13561,"price":120.26,"value":1630845.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $119.78 to $120.78, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":412811,"source":{"system":"sec-edgar","filing":"0001209191-18-056571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056571/doc4.xml","form_type":"4"}},{"id":3842572,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-08-16T11:30:46.000Z","date":"2018-08-15","kind":"purchase","acquired":true,"shares":16000,"price":125.2632,"value":2004211.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $123.97 to $126.00, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above."}],"balance_after":399250,"source":{"system":"sec-edgar","filing":"0001209191-18-046916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118046916/doc4.xml","form_type":"4"}},{"id":3882674,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-06-27T21:24:51.000Z","date":"2018-06-26","kind":"tax_withholding","acquired":false,"shares":36946,"price":135.53,"value":5007291.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017."}],"balance_after":383250,"source":{"system":"sec-edgar","filing":"0001209191-18-039689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118039689/doc4.xml","form_type":"4"}},{"id":4166530,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-11-13T22:00:18.000Z","date":"2017-11-08","kind":"purchase","acquired":true,"shares":38138,"price":52.44,"value":1999956.72,"ownership":{"direct":true},"balance_after":420196,"source":{"system":"sec-edgar","filing":"0000899243-17-026060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000089924317026060/doc4.xml","form_type":"4"}},{"id":4249646,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-07-28T12:51:45.000Z","date":"2017-07-27","kind":"purchase","acquired":true,"shares":47058,"price":42.5,"value":1999965.0,"ownership":{"direct":true},"balance_after":382058,"source":{"system":"sec-edgar","filing":"0001209191-17-046510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117046510/doc4.xml","form_type":"4"}},{"id":4271393,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-28T21:50:57.000Z","date":"2017-06-26","kind":"grant","acquired":true,"shares":3300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 26, 2022, subject to the Reporting Person's continued service to the Issuer or a subsidiary thereof from the date of grant through such date, a percentage of the stock options will vest based on the extent to which the compounded annual growth rate (\"CAGR\") of the Issuer's stock price from June 26, 2017 (based on the closing price on such date) through June 26, 2022 (based on the average of the closing price of the Issuer's common stock on the 20 days immediately preceding such date) exceeds the CAGR of the NASDAQ Biotech Index (or any successor index) during the same period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In certain situations, the stock options will expire within twelve months of such situation, but in no event will the stock options be exercisable after June 26, 2027."}],"balance_after":3300000,"derivative":{"exercise_price":34.65,"expiration_date":"2027-06-26","underlying":"Common Stock","underlying_shares":3300000},"source":{"system":"sec-edgar","filing":"0001209191-17-042164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117042164/doc4.xml","form_type":"4"}},{"id":4271392,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-28T21:50:57.000Z","date":"2017-06-26","kind":"grant","acquired":true,"shares":335000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock. Twenty-five percent of the shares will vest on June 26, 2018 and one thirty-sixth of the remaining unvested shares will vest on each monthly anniversary of June 26 thereafter, ending on June 26, 2021, in each case subject to the Reporting Person's continued service to the Issuer or a subsidiary thereof from the date of grant through each applicable vesting date."}],"balance_after":335000,"source":{"system":"sec-edgar","filing":"0001209191-17-042164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117042164/doc4.xml","form_type":"4"}},{"id":4285304,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-13T01:40:45.000Z","date":"2017-06-09","kind":"tax_withholding","acquired":false,"shares":11488,"price":11.49,"value":131997.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Ingram's tax withholding obligations on shares acquired."}],"balance_after":17336,"source":{"system":"sec-edgar","filing":"0001209191-17-039330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190644/000120919117039330/doc4.xml","form_type":"4"}},{"id":4285303,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-13T01:40:45.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":23934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Mr. Ingram on June 9, 2017 in consideration of his services on Endo International plc's Board of Directors."}],"balance_after":28824,"source":{"system":"sec-edgar","filing":"0001209191-17-039330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190644/000120919117039330/doc4.xml","form_type":"4"}}]}